Renhuang Pharmaceuticals, Inc. (RHGP.OB) Receives Target Price of $7.00
Renhuang Pharmaceuticals, Inc (RHGP.OB) has been rated 'Outperform' with a price target of $7.00 by Beacon Equity Research. Renhuang Pharmaceutical is a company focused on developing, manufacturing, and distributing high quality natural medicine and bio-pharmaceutical products in China. Currently, the company offers three main product lines: Acanthopanax-based natural medicinal products, the Shark Power healthcare series, and Traditional Chinese Medicines. Sales for each product represent 50%, 20% and 30%, respectively. Renhuang has also established a multi-channel research and development infrastructure in China. This infrastructure consists of 50 in-house researchers and engineers, a post-doctoral work center supported by the Chinese government, and…